Multiple Sclerosis Journal - October 2017 - 1549
LE van den Akker, H Beckerman et al.
Table 2. (Continued)
Baseline
RAP self-care (0-10)a
RAP occupational (0-14)a
RAP relationships (0-9)a
CBT
Control
CBT
Control
CBT
Control
T8
T16
T26
T52
Mean (SD)
n
Mean (SD)
n
Mean (SD)
n
Mean (SD)
n
Mean (SD)
n
10.1 (2.8)
9.4 (2.3)
7.3 (1.9)
6.9 (2.0)
5.0 (2.1)
4.2 (1.9)
42
45
42
44
44
45
9.3 (2.1)
9.8 (2.4)
6.4 (2.0)
7.4 (2.6)
4.0 (1.9)
3.7 (1.5)
41
42
40
42
41
42
9.8 (2.3)
9.3 (2.5)
6.7 (4.0)
6.7 (2.2)
3.7 (1.6)
3.5 (1.3)
39
41
41
41
41
42
10.3 (4.2)
9.9 (2.6)
6.4 (2.3)
7.2 (2.0)
3.7 (1.7)
3.5 (1.3)
38
38
38
35
40
37
10.3 (2.8)
10.4 (2.4)
7.2 (2.1)
7.1 (2.0)
4.2 (1.9)
3.7 (1.4)
39
38
38
39
37
39
CBT: cognitive behavioral therapy; CIS20r: Checklist Individual Strength; IPA: Impact on Participation and Autonomy; FSS: Fatigue Severity Scale; MFIS:
Modified Fatigue Impact Scale; SF: Short Form; RAP: Rehabilitation Activity Profile; SD: standard deviation.
aLower is better.
cessation. Summarizing the results, the study found
positive short-term effects of CBT on MS-related
fatigue compared to the MS nurse consultations.
The results regarding societal participation were not
as positive. Except for one positive and significant
result on IPA work and education at T26, we found no
significant effect of CBT compared to the MS nurse
control condition. The participants did not show substantial limitations on the IPA at baseline, which could
be interpreted as a ceiling effect; there was little room
for improvement. Furthermore, a note of caution
about the interpretation of the IPA is due here; it might
not be the most suitable tool to measure societal participation. However, the secondary participation
measures, SF36 and RAP, also failed to show significant between-group differences, with the exception of
SF36 physical role functioning at T8. This leads us to
conclude that CBT for MS-related fatigue did not
influence participation in this study.
Some strengths of this study need to be highlighted.
First of all, we had a follow-up period of 1 year. Only
three studies have provided long-term (8-12 months)
follow-up data.10,26,27 A second (methodological)
strength of the current study was that we excluded
patients with fatigue potentially caused by other factors (e.g. depression, primary sleep disorders). This
led to the inclusion of patients with primary
MS-related fatigue and the results can therefore be
generalized to any ambulant population with primary
MS-related fatigue. It should be noted that only 5% of
the patient population that was assessed for eligibility
was excluded because of high depression scores (see
flow chart), which indicates that the vast majority of
this source population suffers from pure primary
MS-related fatigue. A third strength of the current
study was that the therapy was only provided by
certified psychologists with CBT training. A fourth
journals.sagepub.com/home/msj
strength was that both interventions were delivered by
multiple independent therapists, which decreases the
risk of contamination between study groups and
increases the generalizability of the study results to
other clinical settings and therapists. Finally, this is
the first study in which CBT was tailored to the
patients' needs, that is, only modules were applied
that were relevant for the patient as shown by the
baseline assessment of perpetuating factors, whereas
previous CBT studies used a fixed treatment
protocol.28
Some limitations should be considered when interpreting the results. First, recruitment bias might have
occurred toward patients who were highly motivated
to start with CBT and who were willing to be treated
by a psychologist.29 The fast drop-out of five persons
in the MS nurse study group is likely related to patient
preferences and the disappointment about treatment
allocation. Furthermore, drop-out and treatment
adherence might be caused by attentional problems
and impaired working memory. However, the number
of drop-outs was still lower than the 20% that we
accounted for. Second, in this type of research, it is
hard to control for all non-specific treatment effects.
However, three MS nurse consultations was the maximum amount of sessions, since providing more sessions would be regarded as an intervention, rather
than a control condition. Finally, CBT is an expensive
and intensive treatment. However, even more expensive and intensive treatment with unknown effectiveness is provided for MS-related fatigue. Therefore,
searching for new methods to provide CBT, with the
use of for example e-health methods, might provide a
solution.
This study makes several noteworthy contributions
to the field of CBT treatment of MS-related fatigue.
The current results seem to be consistent with the
1549
https://journals.sagepub.com/home/msj
Table of Contents for the Digital Edition of Multiple Sclerosis Journal - October 2017
Contents
Multiple Sclerosis Journal - October 2017 - Cover1
Multiple Sclerosis Journal - October 2017 - Cover2
Multiple Sclerosis Journal - October 2017 - Contents
Multiple Sclerosis Journal - October 2017 - ii
Multiple Sclerosis Journal - October 2017 - iii
Multiple Sclerosis Journal - October 2017 - 1436
Multiple Sclerosis Journal - October 2017 - 1437
Multiple Sclerosis Journal - October 2017 - 1438
Multiple Sclerosis Journal - October 2017 - 1439
Multiple Sclerosis Journal - October 2017 - 1440
Multiple Sclerosis Journal - October 2017 - 1441
Multiple Sclerosis Journal - October 2017 - 1442
Multiple Sclerosis Journal - October 2017 - 1443
Multiple Sclerosis Journal - October 2017 - 1444
Multiple Sclerosis Journal - October 2017 - 1445
Multiple Sclerosis Journal - October 2017 - 1446
Multiple Sclerosis Journal - October 2017 - 1447
Multiple Sclerosis Journal - October 2017 - 1448
Multiple Sclerosis Journal - October 2017 - 1449
Multiple Sclerosis Journal - October 2017 - 1450
Multiple Sclerosis Journal - October 2017 - 1451
Multiple Sclerosis Journal - October 2017 - 1452
Multiple Sclerosis Journal - October 2017 - 1453
Multiple Sclerosis Journal - October 2017 - 1454
Multiple Sclerosis Journal - October 2017 - 1455
Multiple Sclerosis Journal - October 2017 - 1456
Multiple Sclerosis Journal - October 2017 - 1457
Multiple Sclerosis Journal - October 2017 - 1458
Multiple Sclerosis Journal - October 2017 - 1459
Multiple Sclerosis Journal - October 2017 - 1460
Multiple Sclerosis Journal - October 2017 - 1461
Multiple Sclerosis Journal - October 2017 - 1462
Multiple Sclerosis Journal - October 2017 - 1463
Multiple Sclerosis Journal - October 2017 - 1464
Multiple Sclerosis Journal - October 2017 - 1465
Multiple Sclerosis Journal - October 2017 - 1466
Multiple Sclerosis Journal - October 2017 - 1467
Multiple Sclerosis Journal - October 2017 - 1468
Multiple Sclerosis Journal - October 2017 - 1469
Multiple Sclerosis Journal - October 2017 - 1470
Multiple Sclerosis Journal - October 2017 - 1471
Multiple Sclerosis Journal - October 2017 - 1472
Multiple Sclerosis Journal - October 2017 - 1473
Multiple Sclerosis Journal - October 2017 - 1474
Multiple Sclerosis Journal - October 2017 - 1475
Multiple Sclerosis Journal - October 2017 - 1476
Multiple Sclerosis Journal - October 2017 - 1477
Multiple Sclerosis Journal - October 2017 - 1478
Multiple Sclerosis Journal - October 2017 - 1479
Multiple Sclerosis Journal - October 2017 - 1480
Multiple Sclerosis Journal - October 2017 - 1481
Multiple Sclerosis Journal - October 2017 - 1482
Multiple Sclerosis Journal - October 2017 - 1483
Multiple Sclerosis Journal - October 2017 - 1484
Multiple Sclerosis Journal - October 2017 - 1485
Multiple Sclerosis Journal - October 2017 - 1486
Multiple Sclerosis Journal - October 2017 - 1487
Multiple Sclerosis Journal - October 2017 - 1488
Multiple Sclerosis Journal - October 2017 - 1489
Multiple Sclerosis Journal - October 2017 - 1490
Multiple Sclerosis Journal - October 2017 - 1491
Multiple Sclerosis Journal - October 2017 - 1492
Multiple Sclerosis Journal - October 2017 - 1493
Multiple Sclerosis Journal - October 2017 - 1494
Multiple Sclerosis Journal - October 2017 - 1495
Multiple Sclerosis Journal - October 2017 - 1496
Multiple Sclerosis Journal - October 2017 - 1497
Multiple Sclerosis Journal - October 2017 - 1498
Multiple Sclerosis Journal - October 2017 - 1499
Multiple Sclerosis Journal - October 2017 - 1500
Multiple Sclerosis Journal - October 2017 - 1501
Multiple Sclerosis Journal - October 2017 - 1502
Multiple Sclerosis Journal - October 2017 - 1503
Multiple Sclerosis Journal - October 2017 - 1504
Multiple Sclerosis Journal - October 2017 - 1505
Multiple Sclerosis Journal - October 2017 - 1506
Multiple Sclerosis Journal - October 2017 - 1507
Multiple Sclerosis Journal - October 2017 - 1508
Multiple Sclerosis Journal - October 2017 - 1509
Multiple Sclerosis Journal - October 2017 - 1510
Multiple Sclerosis Journal - October 2017 - 1511
Multiple Sclerosis Journal - October 2017 - 1512
Multiple Sclerosis Journal - October 2017 - 1513
Multiple Sclerosis Journal - October 2017 - 1514
Multiple Sclerosis Journal - October 2017 - 1515
Multiple Sclerosis Journal - October 2017 - 1516
Multiple Sclerosis Journal - October 2017 - 1517
Multiple Sclerosis Journal - October 2017 - 1518
Multiple Sclerosis Journal - October 2017 - 1519
Multiple Sclerosis Journal - October 2017 - 1520
Multiple Sclerosis Journal - October 2017 - 1521
Multiple Sclerosis Journal - October 2017 - 1522
Multiple Sclerosis Journal - October 2017 - 1523
Multiple Sclerosis Journal - October 2017 - 1524
Multiple Sclerosis Journal - October 2017 - 1525
Multiple Sclerosis Journal - October 2017 - 1526
Multiple Sclerosis Journal - October 2017 - 1527
Multiple Sclerosis Journal - October 2017 - 1528
Multiple Sclerosis Journal - October 2017 - 1529
Multiple Sclerosis Journal - October 2017 - 1530
Multiple Sclerosis Journal - October 2017 - 1531
Multiple Sclerosis Journal - October 2017 - 1532
Multiple Sclerosis Journal - October 2017 - 1533
Multiple Sclerosis Journal - October 2017 - 1534
Multiple Sclerosis Journal - October 2017 - 1535
Multiple Sclerosis Journal - October 2017 - 1536
Multiple Sclerosis Journal - October 2017 - 1537
Multiple Sclerosis Journal - October 2017 - 1538
Multiple Sclerosis Journal - October 2017 - 1539
Multiple Sclerosis Journal - October 2017 - 1540
Multiple Sclerosis Journal - October 2017 - 1541
Multiple Sclerosis Journal - October 2017 - 1542
Multiple Sclerosis Journal - October 2017 - 1543
Multiple Sclerosis Journal - October 2017 - 1544
Multiple Sclerosis Journal - October 2017 - 1545
Multiple Sclerosis Journal - October 2017 - 1546
Multiple Sclerosis Journal - October 2017 - 1547
Multiple Sclerosis Journal - October 2017 - 1548
Multiple Sclerosis Journal - October 2017 - 1549
Multiple Sclerosis Journal - October 2017 - 1550
Multiple Sclerosis Journal - October 2017 - 1551
Multiple Sclerosis Journal - October 2017 - 1552
Multiple Sclerosis Journal - October 2017 - 1553
Multiple Sclerosis Journal - October 2017 - 1554
Multiple Sclerosis Journal - October 2017 - 1555
Multiple Sclerosis Journal - October 2017 - 1556
Multiple Sclerosis Journal - October 2017 - 1557
Multiple Sclerosis Journal - October 2017 - 1558
Multiple Sclerosis Journal - October 2017 - 1559
Multiple Sclerosis Journal - October 2017 - 1560
Multiple Sclerosis Journal - October 2017 - 1561
Multiple Sclerosis Journal - October 2017 - 1562
Multiple Sclerosis Journal - October 2017 - 1563
Multiple Sclerosis Journal - October 2017 - 1564
Multiple Sclerosis Journal - October 2017 - 1565
Multiple Sclerosis Journal - October 2017 - 1566
Multiple Sclerosis Journal - October 2017 - Cover3
Multiple Sclerosis Journal - October 2017 - Cover4
https://www.nxtbookmedia.com